← All stocks

Tectonic Therapeutic, Inc.

TECX Net buying
CIK 0001681087 #2839 in the set updated 18 Sep 2026
Bought (120 mo)
$93.83M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$12.26M
$440.63K on a plan · $198.03K straight out of an exercise
Sold at will
$11.62M
12 of 22 sales
Net
+$81.58M
+$82.22M against sales at will

By person

27 insiders · 60 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SPRINGER TIMOTHY A
Director
$62.37M (17)
+$62.37M
5,838,204
29.86%
$213.21M
Atlas Venture Fund X, L.P. entity
10% owner
$15.00M (1)
+$15.00M
5,567,289
28.48%
$203.32M
Booth Bruce
Director
$15.00M (1)
+$15.00M
5,567,289
28.48%
$203.32M
MCGUIRE TERRANCE
Director
$8.55M (1)
−$8.55M
573,062
2.93%
$20.93M
MACKAY GEOFFREY
President & CEO
$2.16M (5)
−$2.16M
978,343
5.00%
$35.73M
+27.3%
Leonard Braden Michael
Former 10% owner of AVROBIO
$971.49K (3)
+$971.49K
433,688
2.22%
$15.84M
PAIGE CHRISTOPHER
Director
$907.20K (6)
−$907.20K
252,512
1.29%
$9.22M
−12.2%
Lochner Daniel
Chief Financial Officer
$379.62K (2)
+$379.62K
58,544
0.2995%
$2.14M
Ruddy Marcella K.
Chief Medical Officer
$363.00K (3) scheduled
−$363.00K
67,682
0.3462%
$2.47M
McNamara Peter
Chief Scientific Officer
$275.66K (7) scheduled
−$275.66K
55,285
0.2828%
$2.02M
REICIN ALISE
Chief Executive Officer
$52.75K (1)
+$52.75K
435,153
2.23%
$15.89M
Vickers Philip J.
Director
$40.08K (1)
+$40.08K
4,800
0.0246%
$175.30K
Donenberg Phillip B.
Director
$23.42K (1)
+$23.42K
2,000
0.0102%
$73.04K
Clarus Lifesciences III, L.P.
10% owner
4,443,487
22.73%
$162.28M
+50.0%
ATLAS VENTURE ASSOCIATES X, L.P. entity
10% owner
3,710,052
18.98%
$135.49M
−22.0%
Requadt Scott
Director
2,962,325
15.15%
$108.18M
Cortis Christian
Chief Operating Officer
126,368
0.6464%
$4.61M
SVLSF VI, LLC entity
10% owner
63,913
0.3269%
$2.33M
Golipour Azadeh
Chief Technology Officer
55,872
0.2858%
$2.04M
+53.7%
Schwabish Marc
Chief Business Officer
45,314
0.2318%
$1.65M
Ostrowski Erik
Interim CEO, President and CFO
29,285
0.1498%
$1.07M
Vitorovic Stefan
Director
27,774
0.1421%
$1.01M
Avruch Steven
Chief Legal Officer
22,022
0.1126%
$804.24K
Ridha Essra
Chief Medical Officer
15,881
0.0812%
$579.97K
Dorton Katina
Chief Financial Officer
10,000
0.0512%
$365.20K
Tipirneni Praveen P.
Director
3,037
0.0155%
$110.91K
KREHER NERISSA
Chief Medical Officer
2,942
0.0150%
$107.44K
Insider
Date
Role
Action
Shares
Price
Amount
MCGUIRE TERRANCE
7 Apr 2025
Director
Sell indirect
500,000
$17.10
$8.55M
MACKAY GEOFFREY
12 Feb 2020
See Remarks
Sell
1,400
$29.07
$40.69K
MACKAY GEOFFREY
11 Feb 2020
See Remarks
Sell
18,404
$28.10
$517.10K
MACKAY GEOFFREY
11 Feb 2020
See Remarks
Sell
44,596
$27.36
$1.22M
PAIGE CHRISTOPHER
11 Feb 2020
Director
Sell
15,000
$28.00
$420.00K
PAIGE CHRISTOPHER
28 Jan 2020
Director
Sell
10,000
$23.00
$230.00K
MACKAY GEOFFREY
8 Apr 2019
See Remarks
Sell
698
$27.07
$18.89K
PAIGE CHRISTOPHER
8 Apr 2019
Director
Sell
100
$26.92
$2.69K
PAIGE CHRISTOPHER
8 Apr 2019
Director
Sell
2,400
$25.84
$62.02K
MACKAY GEOFFREY
5 Apr 2019
See Remarks
Sell
13,302
$27.26
$362.62K
PAIGE CHRISTOPHER
5 Apr 2019
Director
Sell
867
$26.21
$22.72K
PAIGE CHRISTOPHER
5 Apr 2019
Director
Sell
6,633
$25.59
$169.76K

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 5
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 32,676,486
Sales filed before the plan box existed 11
History held since 22 Jun 2018